DAFNA Capital Management LLC
Filing Date
Global Rank
#2,729
/ 8,232
▲ 213
Top Industry
Biotechnology
69.8%
3Y Alpha vs SPY
+0.7%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+79.2%
SPY
+76.3%
Annualised alpha
+0.7%
Max drawdown
−42.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
79 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
14.8%
+1.7 pts
Top 5
35.4%
−3.8 pts
Top 10
52.1%
−3.3 pts
HHI
444
Diversified−9
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $382,680,155 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
20 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | +1,607,836 | 2,418,882 | $13,376,417 | |
| LRMR | Larimar Therapeutics, Inc. | +1,090,000 | 2,029,164 | $9,131,238 | |
| ARAY | Accuray Inc | +285,000 | 1,680,508 | $655,398 | |
| BCAX | Bicara Therapeutics Inc. | +160,150 | 421,733 | $8,388,269 | |
| NKTR | Nektar Therapeutics | +90,180 | 165,178 | $11,884,557 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +45,100 | 61,100 | $1,280,045 | |
| HELP | Cybin Inc. | +43,343 | 498,361 | $2,392,132 | |
| LXEO | Lexeo Therapeutics, Inc. | +36,200 | 377,059 | $2,164,318 | |
| NGNE | Neurogene Inc. | +28,661 | 56,635 | $1,141,761 | |
| MPLT | MapLight Therapeutics, Inc. | +27,242 | 171,006 | $3,476,551 | |
| ENGN | enGene Therapeutics Inc. | +23,708 | 187,353 | $1,275,873 | |
| STOK | Stoke Therapeutics, Inc. | +22,000 | 130,875 | $4,261,290 | |
| INGN | Inogen Inc | +18,108 | 845,179 | $5,223,206 | |
| RCUS | Arcus Biosciences, Inc. | +12,500 | 443,829 | $9,586,706 | |
| BCRX | Biocryst Pharmaceuticals Inc | +11,993 | 430,248 | $4,095,960 | |
| MBX | MBX Biosciences, Inc. | +10,200 | 175,465 | $5,237,630 | |
| INSP | Inspire Medical Systems, Inc. | +9,600 | 18,200 | $938,756 | |
| GPCR | Structure Therapeutics Inc. | +9,500 | 46,500 | $2,241,300 | |
| ALKS | Alkermes plc. | +9,234 | 139,482 | $4,932,083 | |
| PODD | Insulet Corp | +4,000 | 10,870 | $2,280,960 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | −359,233 | 2,434,353 | $5,501,637 | |
| AXGN | Axogen, Inc. | −226,866 | 249,960 | $8,281,174 | |
| ANNX | Annexon, Inc. | −155,000 | 117,812 | $652,678 | |
| CYTK | Cytokinetics Inc | −153,500 | 217,497 | $14,335,227 | |
| BHVN | Biohaven Ltd. | −109,500 | 845,735 | $7,154,918 | |
| KALV | KalVista Pharmaceuticals, Inc. | −89,400 | 267,402 | $5,382,802 | |
| SNDX | Syndax Pharmaceuticals Inc | −60,500 | 217,355 | $5,077,412 | |
| SPRY | ARS Pharmaceuticals, Inc. | −50,780 | 139,285 | $1,118,458 | |
| EWTX | Edgewise Therapeutics, Inc. | −47,500 | 112,236 | $3,535,434 | |
| ORIC | Oric Pharmaceuticals, Inc. | −42,321 | 98,724 | $1,250,833 | |
| XENE | Xenon Pharmaceuticals Inc. | −37,167 | 250,772 | $14,582,391 | |
| IMTX | Immatics N.V. | −35,278 | 225,860 | $2,222,462 | |
| IDYA | IDEAYA Biosciences, Inc. | −30,000 | 476,740 | $15,884,976 | |
| RVMD | Revolution Medicines, Inc. | −23,836 | 580,678 | $56,470,935 | |
| PROF | Profound Medical Corp. | −22,705 | 263,005 | $1,704,272 | |
| DAWN | Day One Biopharmaceuticals, Inc. | −20,700 | 978,463 | $20,978,246 | |
| VRCA | Verrica Pharmaceuticals Inc. | −19,739 | 153,712 | $813,136 | |
| MDWD | MediWound Ltd. | −19,207 | 94,405 | $1,520,864 | |
| FHTX | Foghorn Therapeutics Inc. | −15,000 | 111,859 | $534,686 | |
| CGEN | Compugen Ltd | −14,619 | 257,783 | $549,077 | |
| ALLO | Allogene Therapeutics, Inc. | −10,000 | 1,370,118 | $3,343,087 | |
| AQST | Aquestive Therapeutics, Inc. | −7,500 | 368,415 | $1,528,922 | |
| KPTI | Karyopharm Therapeutics Inc. | −5,200 | 45,800 | $255,106 | |
| ADCT | ADC Therapeutics SA | −5,000 | 72,081 | $270,303 | |
| ASND | Ascendis Pharma A/S | −5,000 | 23,177 | $5,301,275 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 205,000 | $1,572,350 | |
| KIDS | Orthopediatrics Corp | 95,659 | $1,518,108 | |
| CTMX | CytomX Therapeutics, Inc. | 230,000 | $1,081,000 | |
| MAZE | Maze Therapeutics, Inc. | 35,000 | $1,044,750 | |
| SCYX | Scynexis Inc | 1,086,956 | $996,738 | |
| ZBIO | Zenas BioPharma, Inc. | 42,500 | $830,875 | |
| NAMS | NewAmsterdam Pharma Co N.V. | 20,000 | $640,200 | |
| PLRX | Pliant Therapeutics, Inc. | 487,000 | $613,620 | |
| IBIO | iBio, Inc. | 193,638 | $367,912 | |
| No positions match the current search. | ||||
79 positions ·
$382,680,155 total
· as of Mar 31, 2026
Showing 1–50
of 79 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 580,678 | $56,470,935 | 14.76% | |
| STXS |
Stereotaxis, Inc.
Healthcare
|
Held | 13,680,554 | $25,172,219 | 6.58% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
Reduced | 978,463 | $20,978,246 | 5.48% | |
| ATRC |
AtriCure, Inc.
Healthcare
|
Held | 597,431 | $17,044,706 | 4.45% | |
| IDYA |
IDEAYA Biosciences, Inc.
Healthcare
|
Reduced | 476,740 | $15,884,976 | 4.15% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 250,772 | $14,582,391 | 3.81% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Reduced | 217,497 | $14,335,227 | 3.75% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Added | 2,418,882 | $13,376,417 | 3.50% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Added | 165,178 | $11,884,557 | 3.11% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 443,829 | $9,586,706 | 2.51% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 70,615 | $9,302,820 | 2.43% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Added | 2,029,164 | $9,131,238 | 2.39% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 421,733 | $8,388,269 | 2.19% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 249,960 | $8,281,174 | 2.16% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Reduced | 845,735 | $7,154,918 | 1.87% | |
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
Held | 355,208 | $6,809,337 | 1.78% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Held | 318,500 | $6,115,200 | 1.60% | |
| IPSC |
Century Therapeutics, Inc.
Healthcare
|
Reduced | 2,434,353 | $5,501,637 | 1.44% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 86,279 | $5,418,321 | 1.42% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Reduced | 267,402 | $5,382,802 | 1.41% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 23,177 | $5,301,275 | 1.39% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Added | 175,465 | $5,237,630 | 1.37% | |
| INGN |
Inogen Inc
Healthcare
|
Added | 845,179 | $5,223,206 | 1.36% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 217,355 | $5,077,412 | 1.33% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 139,482 | $4,932,083 | 1.29% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 130,875 | $4,261,290 | 1.11% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 430,248 | $4,095,960 | 1.07% | |
| LKFT |
Lakefront Biotherapeutics NV
Healthcare
|
Held | 130,175 | $3,905,250 | 1.02% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
Held | 150,524 | $3,739,016 | 0.98% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Reduced | 112,236 | $3,535,434 | 0.92% | |
| MPLT |
MapLight Therapeutics, Inc.
Healthcare
|
Added | 171,006 | $3,476,551 | 0.91% | |
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
Reduced | 1,370,118 | $3,343,087 | 0.87% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
Held | 120,000 | $3,001,200 | 0.78% | |
| ALGN |
Align Technology Inc
Healthcare
|
Reduced | 15,000 | $2,571,450 | 0.67% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 1,567,561 | $2,539,448 | 0.66% | |
| HELP |
Cybin Inc.
Healthcare
|
Added | 498,361 | $2,392,132 | 0.63% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Held | 75,000 | $2,346,750 | 0.61% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 10,870 | $2,280,960 | 0.60% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 46,500 | $2,241,300 | 0.59% | |
| IMTX |
Immatics N.V.
Healthcare
|
Reduced | 225,860 | $2,222,462 | 0.58% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Held | 68,518 | $2,173,390 | 0.57% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Added | 377,059 | $2,164,318 | 0.57% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 908,351 | $1,952,954 | 0.51% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
Held | 59,516 | $1,936,650 | 0.51% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 235,868 | $1,917,606 | 0.50% | |
| PROF |
Profound Medical Corp.
Healthcare
|
Reduced | 263,005 | $1,704,272 | 0.45% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
NEW | 205,000 | $1,572,350 | 0.41% | |
| AQST |
Aquestive Therapeutics, Inc.
Healthcare
|
Reduced | 368,415 | $1,528,922 | 0.40% | |
| MDWD |
MediWound Ltd.
Healthcare
|
Reduced | 94,405 | $1,520,864 | 0.40% | |
| KIDS |
Orthopediatrics Corp
Healthcare
|
NEW | 95,659 | $1,518,108 | 0.40% |